The HCPLive Gastroenterology condition center page is a comprehensive resource for clinical news and insights on digestive and GI conditions. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for C difficile, IBS and IBD, Crohn's disease, and more.
November 22nd 2024
The supplemental Biologics License Application is supported by the phase 3 ASTRO study of guselkumab SC induction therapy in ulcerative colitis.
Promising Developments in Fecal Microbiota Transplantation
Researchers have made several impressive advances in gastrointestinal medicine in recent years, including the use of fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infection. Following the success of that approach, researchers have been evaluating FMT for the treatment of other conditions, with one team recently conducting the first randomized controlled trial of FMT to treat inflammatory bowel disease (IBD).
Merck Looks to Become Bigger Player in Hepatitis C Market with Acquisition
Between developing its own pipeline of therapies for patients with hepatitis C and acquiring another company known for its work in this field, it looks like Merck is taking steps to be a larger player in HCV market.
Acute Hepatitis C on the Rise Among Young People
August 19th 2014An emerging epidemic of acute hepatitis C threatens the country's younger population, which experienced a significant hike in the number of cases during a recent 6-year period, according to a compound study that looked at trends of the disease among youth.
Steps for Primary Care Providers to Improve Opioid Prescribing for Chronic Pain
One of the most common treatment courses for chronic pain is comprised of prescription opioid medications. However, concerns about drug addiction and abuse oftentimes outweigh the drugs' pain-relieving benefits.
Hyperpigmented Back Lesion in a Young Woman
July 22nd 2014This 28-year-old woman presented with a large hyperpigmented patch on the right side of her upper back. Although the lesion developed over the past 2 years, it has been "sinking in" over the past 2 weeks. The patient denies any trauma, pain, discomfort, or pruritis, as well as any family history of cancers, lymphoma, or autoimmune disease. However, she has a history of gastroesophageal reflux disease and onychomycosis, and her grandfather has a similar lesion.
Recovery Trajectories for Short-stay Surgery Vary Considerably
July 22nd 2014Though hospital stay duration was once used as a surrogate outcome for surgical recovery, the increasing popularity of short-stay surgery has eliminated that measure, making it harder for hospitals to track recovery trajectories and more difficult for surgeons to plan physical, psychological, and social postoperative courses for prospective patients.
Steps to Minimize Serious Risks of Biologic Treatment for Autoimmune Disease
July 19th 2014Although tumor necrosis factor inhibitors have dramatically improved management strategies for autoimmune disorders such as rheumatoid arthritis and inflammatory bowel disease, the biologic agents also pose a number of significant side effects that physicians must consider.
To Answer Patient Questions, Physicians Turn to New Information Sources
July 14th 2014In a recent survey, physicians identified peer-reviewed journal articles, continuing medical education, evidence-based guidelines, and national experts as the most useful sources of information to stay current on therapeutic advances.